Cite
HARVARD Citation
Castillo, J. et al. (2023). Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States. EJHaem. 4 (1), pp. 301-304. [Online].